Post-authorisation measures (recommendations, conditions and specific obligations): veterinary medicines
Agenda of the CVMP meeting 16-18 July 2024
Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group
Applications for new human medicines under evaluation: July 2024
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 22 May 2024, 10:00 (CEST) to 22 May 2024, 13:30 (CEST)
Meeting summary - Medicine Shortages SPOC Working Party meeting on 22 May 2024
Opinion/decision on a Paediatric investigation plan (PIP): Sotyktu, Deucravacitinib, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0250/2023
Opinion/decision on a Paediatric investigation plan (PIP): Cosentyx, Secukinumab, decision type: W: decision granting a waiver in all age groups for all conditions or indications, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0282/2023
List of industry subject matter experts and list of planned calls for industry subject matter experts
Herbal medicinal product: Ginseng radixArray, F: Assessment finalised